We are live on ! Find out more
BIOSW

BioPlus Acquisition Corp. Warrants
BIOSW

Delisted

BIOSW was delisted on the 6th of October, 2023.

Back to rankings

46 hedge funds and large institutions have $560K invested in BioPlus Acquisition Corp. Warrants in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

5% more funds holding

Funds holding: 44 → 46 (+2)

58% less capital invested

Capital invested by funds: $1.35M → $560K (-$785K)

Holders
46
Holders Change
+2
Holders Change %
+4.55%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
3
Closed
2
Calls
$2.55M
Puts
–
Net Calls
+$2.55M
Net Calls Change
+$1.69M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$10.8K
2
Walleye Capital
Walleye Capital
New York
+$9.57K
3
CAC
Cowen and Company
New York
+$7.31K
4
VF
Virtu Financial
New York
+$6.39K
5
Walleye Trading
Walleye Trading
New York
+$5.38K

Top Sellers

Rank Fund Capital Flow
1
SFM
Spartan Fund Management
Canada
-$51.7K
2
AMH
Apollo Management Holdings
New York
-$18.4K
3
TI
Tidal Investments
Wisconsin
-$2K
4
RCM
Robinson Capital Management
Michigan
-$1.23K
5
CSS
Cubist Systematic Strategies
Connecticut
-$1.08K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Saba Capital Management
New York
$52.7K – – –
PC
2
Periscope Capital
Ontario, Canada
$48.6K – – –
LA
3
Linden Advisors
New York
$34.9K – – –
PAMP
4
Polar Asset Management Partners
Ontario, Canada
$33.7K – – –
CAC
5
Cowen and Company
New York
$29.2K +$7.31K +61,109 +13%
SCM
6
Shaolin Capital Management
Florida
$29K +$3.08K +25,756 +5%
Calamos Advisors
7
Calamos Advisors
Illinois
$28K – – –
Goldman Sachs
8
Goldman Sachs
New York
$23.1K – – –
MI
9
MMCAP International
Cayman Islands
$18.2K – – –
SC
10
Sculptor Capital
New York
$16.8K – – –
AA
11
AQR Arbitrage
Connecticut
$16.5K – – –
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$15.3K – – –
CSS
13
Cubist Systematic Strategies
Connecticut
$14.1K -$1.08K -9,000 -3%
CF
14
Cantor Fitzgerald
New York
$14K – – –
DKCM
15
Davidson Kempner Capital Management
New York
$14K – – –
TCA
16
Taconic Capital Advisors
New York
$14K – – –
RCM
17
Radcliffe Capital Management
Pennsylvania
$13.9K – – –
UOC
18
UBS O'Connor
Illinois
$12.7K – – –
KL
19
KIM LLC
Kansas
$12.3K – – –
HIM
20
HGC Investment Management
Ontario, Canada
$11.2K – – –
QGA
21
Q Global Advisors
Texas
$11K – – –
Walleye Capital
22
Walleye Capital
New York
$9.85K +$9.57K +80,000 +83%
CS
23
Clear Street
New York
$7.76K – – –
ACM
24
Atalaya Capital Management
New York
$7.5K – – –
EFI
25
EHP Funds Inc
Canada
$7.01K – – –
1
2

BIOSW Hedge Fund Activity: Q3 2023 in Review

46 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Warrants (BIOSW) for Q3 2023, worth a combined $560K — down 58% from $1.35M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BIOSW positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $10.8K. The largest seller was Spartan Fund Management, cutting an estimated $51.7K.

  • 46 institutional investors held BioPlus Acquisition Corp. Warrants (BIOSW) as of Q3 2023, up from 44 in Q2 2023.
  • Funds reported $560K of BioPlus Acquisition Corp. Warrants stock for Q3 2023, down 58% quarter-over-quarter.
  • 4 funds opened new BioPlus Acquisition Corp. Warrants positions in Q3 2023 and 2 closed out, a net change of +2 holders.
  • The largest BioPlus Acquisition Corp. Warrants buyer in Q3 2023 was Susquehanna International Group, an estimated $10.8K added.
  • The largest BioPlus Acquisition Corp. Warrants seller in Q3 2023 was Spartan Fund Management, an estimated $51.7K sold.

Based on aggregated 13F filings for Q3 2023.